Pharos iBio Co., Ltd. (KOSDAQ:388870)
South Korea · Delayed Price · Currency is KRW 5,310.00
+220.00 (4.32%)
At close: Aug 24, 2026
Pharos iBio Market Cap
Pharos iBio has a market cap or net worth of 65.89 billion as of August 21, 2026. Its market cap has decreased by -11.01% in one year.
Market Cap
65.89B
Enterprise Value
52.46B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
5,310.00
ChartMarket Cap Chart
Since July 27, 2023, Pharos iBio's market cap has decreased from 112.78B to 65.89B, a decrease of -41.57%. That is a compound annual growth rate of -16.05%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 65.89B | -45.79% |
| Dec 30, 2025 | 121.56B | 24.04% |
| Dec 30, 2024 | 98.00B | -48.85% |
| Dec 28, 2023 | 191.59B | 69.87% |
| Jul 27, 2023 | 112.78B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sam-A Pharm. | 83.55B |
| KOREA PHARMA | 82.24B |
| Daehan Nupharm | 78.32B |
| Polaris AI Pharma | 68.41B |
| Optipharm.CO.,LTD | 66.97B |
| Hwail Pharmaceutical | 66.84B |
| Sinsin Pharmaceutical | 66.30B |
| Sinil Pharmaceutical | 66.21B |